Fig. 1: The BH4 domains of Bcl-2 and Bcl-XL inhibit RyR-mediated Ca2+ release in PACs.
From: BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis

a Linear representation of the Bcl-2/Bcl-XL protein together with the sequences used to design the BH4 domain peptides originating from Bcl-2 and Bcl-XL and the predicted secondary structure using the PSIPRED secondary structure predictor (http://bioinf.cs.ucl.ac.uk/psipred/). bād Typical traces of the Fluo-4AM single-cell Ca2+ measurements performed in mouse PACs. At the start of each experiment cells were perfused with NaHEPES containing DMSO (vehicle). After establishing the baseline (200ās), CCK (5āpM) was added and RyR-mediated Ca2+ oscillations were measured for 5āmin. Then, 50āµM of either the control peptide (b), the BH4 domain of Bcl-2 (c), or the BH4 domain of Bcl-XL (d) were added for 10āmin, in the continuous presence of 5āpM CCK. e Quantification of the experiments: The area under the curve per second (AUC/sec) of the CCK-induced Ca2+ release after peptide addition (10āmin recording) was compared to the AUC/sec before peptide addition (5āmin recording). Each data point represents the measurement of an individual cell. The average valuesā±āSEM are shown (P-value <0.0001). At least three independent experiments were performed per condition (Nāā„ā3). For each condition at least 35 cells were recorded